Top Markets
Coin of the day
Bioptik Technology Incorporation Bioptik Technology Incorporation

Bioptik Technology Incorporation

4161
Classifica tra le azioni #26078
Bioptik Technology Incorporation operates as a global entity, focusing on the... Bioptik Technology Incorporation operates as a global entity, focusing on the creation and distribution of medical instruments and diagnostic chemicals. The company's product line encompasses the EasyMate series of blood glucose monitoring systems, as well as comprehensive diagnostic devices designed to measure blood glucose, cholesterol, and uric acid levels, complete with their essential test strips. Beyond its healthcare offerings, Bioptik also provides a range of skincare solutions, including those formulated with hyaluronic acid, alongside various dietary supplements. Uniquely, the company diversifies its business by supplying biodiesel products. Founded in 1999, Bioptik Technology Incorporation is headquartered in Zhunan, Taiwan.
Prezzo delle azioni
$0.72978769
Capitalizzazione di mercato
$43.65M
Variazione (1 giorno)
1.10%
Variazione (1 anno)
-17.81%
Paese
TW
Scambia Bioptik Technology Incorporation (4161)

Categoria

Storico del rendimento da dividendi per Bioptik Technology Incorporation (4161)
Il rendimento da dividendi (TTM) di Bioptik Technology Incorporation (simbolo azionario: 4161) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per Bioptik Technology Incorporation (4161) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
Azienda Rendimento da dividendi Il paese
2.23%
US
1.03%
US
3.69%
IE
0.00%
US
0.00%
DE